AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33403883 — intervention group
Group type: EXPERIMENTAL
Intervention: Finnish Cancer Registry (FCR) data
Number of subjects: 1475
Study 33403883 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 1475
Study 33403883 — intervention group
Group type: EXPERIMENTAL
Intervention: Missing CRFs from clinicians
Number of subjects: 1475
Study 32361863 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fractionated standard radiotherapy (CRT)
Number of subjects: 394
Study 32361863 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy (SRT)
Number of subjects: 394
Study 35527346 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-guided occult lesion localisation using iodine-125 (125I) seed (ROLLIS)
Number of subjects: 659
Study 35383463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 serial NP measurements (BNP or NT-proBNP)
Number of subjects: 5393
Study 35383463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 serial NP measurements (BNP)
Number of subjects: 5393
Study 35383463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 serial NP measurements (NT-proBNP)
Number of subjects: 5393
Study 35383463 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 serial NP measurements
Number of subjects: 5393
Study 36321951 — intervention group
Group type: EXPERIMENTAL
Intervention: TPGS emulsification of berberine
Number of subjects: 12
Study 36321951 — intervention group
Group type: EXPERIMENTAL
Intervention: Quillaja extract emulsification of berberine
Number of subjects: 12
Study 36321951 — intervention group
Group type: COMPARATOR
Intervention: Berberine powder (control)
Number of subjects: 12
Study 36321951 — intervention group
Group type: EXPERIMENTAL
Intervention: TPGS emulsification
Number of subjects: 12
Study 36321951 — intervention group
Group type: EXPERIMENTAL
Intervention: Quillaja extract emulsification
Number of subjects: 12
Study 36321951 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsification (both TPGS and Quillaja)
Number of subjects: 12
Study 33602433 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal radial access
Number of subjects: 282
Study 33602433 — intervention group
Group type: COMPARATOR
Intervention: Proximal radial access
Number of subjects: 282
Study 32394890 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (40 minutes of supervised aerobic exercise training and 10 minutes of stretching class, 3 times a week for 12 weeks)
Number of subjects: 40
Study 32394890 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 35298426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam plus metronidazole (n = 62)
Number of subjects: 142
Study 35298426 — intervention group
Group type: COMPARATOR
Intervention: Meropenem (n = 63)
Number of subjects: 142
Study 32779386 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter splint (SOVA)
Number of subjects: 67
Study 32779386 — intervention group
Group type: COMPARATOR
Intervention: Gold standard bite splint (Michigan)
Number of subjects: 67
Study 35594284 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin‐tazobactam
Number of subjects: 121
Study 35594284 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 121
Study 33939666 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Auxora plus standard of care (SOC)
Number of subjects: 21
Study 33939666 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Auxora plus standard of care (SOC)
Number of subjects: 21
Study 33939666 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 21
Study 33211607 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS-Plus (provider scripts + patient messages)
Number of subjects: 240
Study 33211607 — intervention group
Group type: COMPARATOR
Intervention: TIPS-Basic (provider scripts only)
Number of subjects: 240
Study 33211607 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS-Plus and TIPS-Basic
Number of subjects: 240
Study 35078021 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity static stretching (HI-SS) intervention group (n = 14; stretch intensity 6–7 out of 10)
Number of subjects: 28
Study 35078021 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity static stretching (LI-SS) intervention group (n = 14; stretch intensity 0–1 out of 10)
Number of subjects: 28
Study 33019950 — intervention group
Group type: EXPERIMENTAL
Intervention: Traffic Light Labelling (TLL)
Number of subjects: 1997
Study 33019950 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Ratings (HSR)
Number of subjects: 1997
Study 33019950 — intervention group
Group type: EXPERIMENTAL
Intervention: 'High in' Warning Labels (WL)
Number of subjects: 1997
Study 33019950 — intervention group
Group type: COMPARATOR
Intervention: Control (no interpretive FOP labelling)
Number of subjects: 1997
Study 33019950 — intervention group
Group type: EXPERIMENTAL
Intervention: All FOP labelling systems
Number of subjects: 1997
Study 32720832 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis Bi‐07, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM) with conventional treatment
Number of subjects: 194
Study 32720832 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without probiotics
Number of subjects: 194
Study 32720832 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics with conventional treatment
Number of subjects: 194
Study 35307306 — intervention group
Group type: EXPERIMENTAL
Intervention: APPv treatment
Number of subjects: 100
Study 35307306 — intervention group
Group type: EXPERIMENTAL
Intervention: APPv-urologist agreement
Number of subjects: 100
Study 32959587 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling
Number of subjects: 30
Study 32959587 — intervention group
Group type: COMPARATOR
Intervention: Simple resistance training (Control)
Number of subjects: 30
Study 34898061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching+Tannic acid+Doulink
Number of subjects: 80
Study 34898061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching+Quercetin+Doulink
Number of subjects: 80
Study 34898061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching+Panavia SA
Number of subjects: 80
Study 34898061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching+Tannic acid+Panavia SA
Number of subjects: 80
Study 34898061 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching+Quercetin+Panavia SA
Number of subjects: 80
Study 34898061 — intervention group
Group type: COMPARATOR
Intervention: Control/Doulink
Number of subjects: 80
Study 34898061 — intervention group
Group type: COMPARATOR
Intervention: Control/PSA
Number of subjects: 80
Study 32006264 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation (20 Hz, 1 W, 30 s)
Number of subjects: 78
Study 32006264 — intervention group
Group type: EXPERIMENTAL
Intervention: Remin Pro paste
Number of subjects: 78
Study 32006264 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser followed by Remin Pro application (group 2)
Number of subjects: 78
Study 32006264 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 78
Study 36443214 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 33
Study 36443214 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 33
Study 33135321 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of CNS tumor survivors
Number of subjects: 0
Study 33135321 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys of CNS tumor survivors
Number of subjects: 0
Study 33135321 — intervention group
Group type: COMPARATOR
Intervention: Matched comparisons (control group)
Number of subjects: 0
Study 32251139 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pamphlets
Number of subjects: 563
Study 32251139 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pamphlets plus text messages
Number of subjects: 563
Study 32251139 — intervention group
Group type: COMPARATOR
Intervention: No education
Number of subjects: 563
Study 36057375 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Better Caregivers (BBC) workshop
Number of subjects: 0
Study 36057375 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study 33630140 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicapone 50 mg
Number of subjects: 391
Study 33630140 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicapone 25 mg
Number of subjects: 391
Study 33630140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 32732928 — intervention group
Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA model
Number of subjects: 338
Study 32732928 — intervention group
Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA score
Number of subjects: 338
Study 32732928 — intervention group
Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA score of 0-2
Number of subjects: 338
Study 35050203 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaled to body weight high-fat meal (9 kcal/kg; 70% fat)
Number of subjects: 16
Study 35050203 — intervention group
Group type: COMPARATOR
Intervention: Standardized high-fat meal containing 75 g of fat (70% fat)
Number of subjects: 16
Study 32236212 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa supplementation (5 g daily, 425 mg of flavanols)
Number of subjects: 0
Study 32236212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34052070 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane (AM) patches
Number of subjects: 50
Study 34052070 — intervention group
Group type: COMPARATOR
Intervention: Biological substitutes
Number of subjects: 50
Study 32484533 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based decision support tool prior to 25 weeks' gestation
Number of subjects: 1485
Study 32484533 — intervention group
Group type: COMPARATOR
Intervention: Usual care (without the tool)
Number of subjects: 1485
Study 35737696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) + Meibomian gland expression (MGX)
Number of subjects: 100
Study 35737696 — intervention group
Group type: COMPARATOR
Intervention: Sham + Meibomian gland expression (MGX)
Number of subjects: 100
Study 34076601 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ASA 300 mg
Number of subjects: 23
Study 34076601 — intervention group
Group type: COMPARATOR
Intervention: Intravenous lysine acetylsalicylate 150 mg
Number of subjects: 23
Study 32326177 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted protein‐fortified human milk (HM)
Number of subjects: 36
Study 32326177 — intervention group
Group type: COMPARATOR
Intervention: Standard fortified human milk (HM)
Number of subjects: 36
Study 32326177 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted protein‐fortified human milk (HM) with at least 30 intervention days
Number of subjects: 36
Study 33998374 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic photography training (20 hours theoretical and 30 hours practice over 8 weeks)
Number of subjects: 20
Study 33998374 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 20
Study 33582692 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block with 2 mg/kg Bupivacaine mixed with 0.75 mcg/kg Dexmedetomidine (Group B)
Number of subjects: 84
Study 33582692 — intervention group
Group type: COMPARATOR
Intervention: Caudal block with 2 mg/kg Bupivacaine (Group A)
Number of subjects: 84
Study 33582692 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 32914876 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI
Number of subjects: 29266
Study 32914876 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (after adjustment for smoking behaviors)
Number of subjects: 29266
Study 32914876 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (UVMR analysis)
Number of subjects: 29266
Study 32914876 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (after adjustment for smoking)
Number of subjects: 29266
Study 32526634 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab plus irinotecan
Number of subjects: 121
Study 32526634 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab plus irinotecan
Number of subjects: 121
Study 35110315 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg TXA
Number of subjects: 0
Study 35110315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33970268 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, and vascular risk management)
Number of subjects: 112
Study 33970268 — intervention group
Group type: COMPARATOR
Intervention: Control group (general health advice)
Number of subjects: 112
Study 35856942 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular recanalization
Number of subjects: 224
Study 34680728 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 400
Study 34680728 — intervention group
Group type: COMPARATOR
Intervention: Usual care with no intervention
Number of subjects: 400
Study 35854106 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (300 mg once a day for 8 weeks)
Number of subjects: 124
Study 35854106 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once a day for 8 weeks)
Number of subjects: 124
Study 32763623 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (200 mg twice per day)
Number of subjects: 43
Study 32763623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 32949071 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D levels
Number of subjects: 0
Study 33308329 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt provision of clozapine for patients with treatment-resistant schizophrenia
Number of subjects: 0
Study 33308329 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal provision of cognitive-behavioural therapy for patients at clinical high risk of psychosis
Number of subjects: 0
Study 33308329 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal provision of family intervention for patients with first-episode psychosis
Number of subjects: 0
Study 33308329 — intervention group
Group type: EXPERIMENTAL
Intervention: Full adherence to the NICE guideline recommendations
Number of subjects: 0
Study 35226357 — intervention group
Group type: EXPERIMENTAL
Intervention: OSNA assay
Number of subjects: 4757
Study 32218418 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver cirrhosis patients
Number of subjects: 81
Study 32218418 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 81
Study 32772857 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention
Number of subjects: 33
Study 32772857 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 33
Study 32473149 — intervention group
Group type: EXPERIMENTAL
Intervention: Height for age z scores (HAZ) in the first two years of life
Number of subjects: 791
Study 32473149 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in HAZ scores between early and later childhood
Number of subjects: 791
Study 34081217 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 0
Study 34081217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32444041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg tablet daily)
Number of subjects: 144
Study 32444041 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch preparation)
Number of subjects: 144
Study 33736674 — intervention group
Group type: EXPERIMENTAL
Intervention: Kai-Hou-Jian spray (children’s type)
Number of subjects: 240
Study 33736674 — intervention group
Group type: COMPARATOR
Intervention: Placebo sprays
Number of subjects: 240
Study 32600336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling therapy initiated before reperfusion
Number of subjects: 77
Study 32600336 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 77
Study 32600336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling therapy and standard of care (pooled cohort)
Number of subjects: 77
Study 35897081 — intervention group
Group type: EXPERIMENTAL
Intervention: MMPR plus sub‐dissociative ketamine infusion
Number of subjects: 0
Study 35897081 — intervention group
Group type: COMPARATOR
Intervention: MMPR
Number of subjects: 0
Study 32461050 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentrically biased flywheel leg-curl training (n=10)
Number of subjects: 20
Study 32461050 — intervention group
Group type: COMPARATOR
Intervention: Conventional flywheel leg-curl training (n=10)
Number of subjects: 20
Study 34787719 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo rotary files (group I)
Number of subjects: 60
Study 34787719 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal rotary files (group II)
Number of subjects: 60
Study 34787719 — intervention group
Group type: EXPERIMENTAL
Intervention: F6 SkyTaper rotary files (group III)
Number of subjects: 60
Study 34787719 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preparation and filling)
Number of subjects: 60
Study 33216360 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of drug
Number of subjects: 0
Study 33216360 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of drug
Number of subjects: 0
Study 33216360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35264408 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 240
Study 35264408 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine hippurate
Number of subjects: 240
Study 34750735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning and greening intervention
Number of subjects: 442
Study 34644317 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (100 mg for three days, given on four occasions at monthly intervals)
Number of subjects: 778
Study 32703340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose naltrexone 6mg daily
Number of subjects: 71
Study 34198230 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126
Study 34198230 — intervention group
Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126
Study 33883876 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal administration of estradiol (E2) and dydrogesterone (DG)
Number of subjects: 20
Study 33883876 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of estradiol (E2) and dydrogesterone (DG)
Number of subjects: 20
Study 32507436 — intervention group
Group type: EXPERIMENTAL
Intervention: Euiiyin-tang
Number of subjects: 149
Study 32507436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 36335914 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily (2.5 mg twice daily for patients ≥80 years or weight ≤60 kg)
Number of subjects: 154
Study 36335914 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 154
Study 36335914 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily
Number of subjects: 154
Study 36335914 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban pharmacokinetics
Number of subjects: 154
Study 34715057 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (10 mg/kg over 2 hours without premedication)
Number of subjects: 105
Study 34715057 — intervention group
Group type: COMPARATOR
Intervention: Second IVIG (2 g/kg over 8-12 hours)
Number of subjects: 105
Study 34715057 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 105
Study 34715057 — intervention group
Group type: COMPARATOR
Intervention: Second IVIG
Number of subjects: 105
Study 34715057 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG (as either first or second treatment)
Number of subjects: 105
Study 34715057 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 105
Study 36253609 — intervention group
Group type: EXPERIMENTAL
Intervention: 3BNC117 + romidepsin
Number of subjects: 55
Study 36253609 — intervention group
Group type: EXPERIMENTAL
Intervention: 3BNC117
Number of subjects: 55
Study 36253609 — intervention group
Group type: COMPARATOR
Intervention: ART only
Number of subjects: 55
Study 32607917 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship education and HIV prevention program for male couples
Number of subjects: 430
Study 32607917 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher rurality
Number of subjects: 430
Study 33049118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd continuous (lenalidomide + low-dose dexamethasone)
Number of subjects: 208
Study 33049118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd18 (fixed-duration lenalidomide + low-dose dexamethasone for 18 cycles)
Number of subjects: 208
Study 33049118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd continuous
Number of subjects: 208
Study 33049118 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd18
Number of subjects: 208
Study 33049118 — intervention group
Group type: COMPARATOR
Intervention: MPT
Number of subjects: 208
Study 35473439 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily dosing of deferasirox
Number of subjects: 41
Study 35473439 — intervention group
Group type: COMPARATOR
Intervention: Once-daily dosing of deferasirox
Number of subjects: 41
Study 34626921 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital educational material + additional virtual interactive epilepsy session
Number of subjects: 130
Study 34626921 — intervention group
Group type: COMPARATOR
Intervention: Digital educational material alone
Number of subjects: 130
Study 32216086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil (7-day course)
Number of subjects: 0
Study 34119470 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous iron therapy
Number of subjects: 2141
Study 34119470 — intervention group
Group type: COMPARATOR
Intervention: Low-dose intravenous iron therapy
Number of subjects: 2141
Study 32379659 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping and lifestyle changes
Number of subjects: 2
Study 32379659 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle changes
Number of subjects: 2